Financial results - RIOVITA MED SRL

Financial Summary - Riovita Med Srl
Unique identification code: 16273406
Registration number: J15/253/2004
Nace: 7500
Sales - Ron
104.937
Net Profit - Ron
45.222
Employee
2
The most important financial indicators for the company Riovita Med Srl - Unique Identification Number 16273406: sales in 2023 was 104.937 euro, registering a net profit of 45.222 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Riovita Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 85.047 71.857 71.614 68.747 70.324 48.138 61.736 87.660 71.628 104.937
Total Income - EUR 86.722 72.908 72.901 69.689 71.232 48.987 67.138 89.021 72.729 111.971
Total Expenses - EUR 71.938 62.578 61.070 60.686 62.323 54.120 65.135 60.093 52.531 65.707
Gross Profit/Loss - EUR 14.784 10.330 11.832 9.003 8.909 -5.133 2.003 28.928 20.198 46.263
Net Profit/Loss - EUR 12.413 8.671 9.926 8.153 8.197 -5.623 1.226 28.038 19.471 45.222
Employees 5 4 3 3 3 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 46.9%, from 71.628 euro in the year 2022, to 104.937 euro in 2023. The Net Profit increased by 25.810 euro, from 19.471 euro in 2022, to 45.222 in the last year.

Check the financial reports for the company - Riovita Med Srl

Rating financiar

Financial Rating -
Riovita Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Riovita Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Riovita Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Riovita Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Riovita Med Srl - CUI 16273406

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 15.165 9.031 272 7 0 16.563 11.249 10.646 4.924 11.138
Current Assets 41.526 46.067 45.366 51.334 56.543 46.332 48.571 73.391 53.363 96.967
Inventories 12.934 14.290 15.042 13.639 12.388 12.873 15.246 17.188 15.172 20.919
Receivables 12.690 13.324 12.837 12.187 20.554 19.510 13.516 22.029 22.296 53.165
Cash 15.902 18.453 17.486 25.508 23.601 13.949 19.809 34.174 15.896 22.883
Shareholders Funds 23.134 31.998 33.015 40.609 48.060 42.485 42.906 69.992 43.052 69.702
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 33.557 23.100 12.623 10.732 8.482 20.409 16.914 14.045 15.235 38.403
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 96.967 euro in 2023 which includes Inventories of 20.919 euro, Receivables of 53.165 euro and cash availability of 22.883 euro.
The company's Equity was valued at 69.702 euro, while total Liabilities amounted to 38.403 euro. Equity increased by 26.781 euro, from 43.052 euro in 2022, to 69.702 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Riovita Med Srl

Comments - Riovita Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.